# Evidence-based Evaluation and Mechanism of Shenhuang Granules in the Treatment of Sepsis

> **NCT06514339** · EARLY_PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Zhejiang Chinese Medical University** · enrollment: 410 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** shenhuang granule
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06514339
- **Lead sponsor:** The First Affiliated Hospital of Zhejiang Chinese Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514339, "Evidence-based Evaluation and Mechanism of Shenhuang Granules in the Treatment of Sepsis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06514339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*